Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$822,862
+$127,112 QoQ
Shares Held
3,270
+2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,727
of 4,150 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Steigerwald, Gordon & Koch Inc. holds $72,202,828 across 15 Drug Manufacturers - General names. ABBV ranks #5 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,876 | $28,921,087 | |
| 2 | AMGN |
Amgen Inc
|
70,256 | $25,441,102 | |
| 3 | PFE |
Pfizer Inc
|
502,925 | $12,110,434 | |
| 4 | LLY |
ELI LILLY & Co
|
2,796 | $3,353,606 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
3,270 | $822,862 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,655 | $598,167 | |
| 7 | NVS |
Novartis AG
|
2,091 | $327,701 | |
| 8 | AZN |
Astrazeneca PLC
|
1,120 | $212,374 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $822,862 | 3,270 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $695,750 | 3,199 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $741,907 | 3,247 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $752,273 | 3,249 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $609,390 | 3,283 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $704,196 | 3,361 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $575,392 | 3,238 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $660,570 | 3,345 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $556,410 | 3,244 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $563,417 | 3,094 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $454,217 | 2,931 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $455,229 | 3,054 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $309,474 | 2,297 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $356,032 | 2,234 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $361,683 | 2,238 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $277,948 | 2,071 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $311,527 | 2,034 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $340,431 | 2,100 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $286,235 | 2,114 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $227,174 | 2,106 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $232,488 | 2,064 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $223,366 | 2,064 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $226,407 | 2,113 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $200,230 | 2,286 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $210,694 | 2,146 | Shares | Sole | 2020-07-14 | |
| No filing history on record for this holder in this stock. | ||||||